 | Up a level |
Béguelin, C; Atkinson, A; Boyd, A; Falconer, K; Kirkby, N; Suter-Riniker, F; Günthard, H F; Rockstroh, J K; Mocroft, A; Rauch, A; Peters, L; Wandeler, G (2023). Hepatitis delta infection among persons living with HIV in Europe. Liver international, 43(4), pp. 819-828. Wiley 10.1111/liv.15519
Kovari, H; Surial, B; Tarr, P E; Cavassini, M; Calmy, A; Schmid, P; Bernasconi, E; Rauch, A; Wandeler, G; Ledergerber, B (2021). Changes in alanine aminotransferase levels after switching from tenofovir disoproxil fumarate (TDF) to tenofovir alafenamide (TAF) in HIV-positive people without viral hepatitis in the Swiss HIV Cohort Study. HIV medicine, 22(7), pp. 623-628. Wiley 10.1111/hiv.13106
Ryom, L; Cotter, A; De Miguel, R; Béguelin, C; Podlekareva, D; Arribas, J R; Marzolini, C; Mallon, Pgm; Rauch, A; Kirk, O; Molina, J M; Guaraldi, G; Winston, A; Bhagani, S; Cinque, P; Kowalska, J D; Collins, S; Battegay, M (2020). 2019 update of the European AIDS Clinical Society Guidelines for treatment of people living with HIV version 10.0. HIV medicine, 21(10), pp. 617-624. Wiley 10.1111/hiv.12878
Hampel, B; Kusejko, K; Kouyos, R D; Böni, J; Flepp, M; Stöckle, M; Conen, A; Béguelin, C; Künzler-Heule, P; Nicca, D; Schmidt, A J; Nguyen, H; Delaloye, J; Rougemont, M; Bernasconi, E; Rauch, A; Günthard, H F; Braun, D L; Fehr, J (2020). Chemsex drugs on the rise: a longitudinal analysis of the Swiss HIV Cohort Study from 2007 to 2017. HIV medicine, 21(4), pp. 228-239. Wiley 10.1111/hiv.12821
Aebi-Popp, K; Wandeler, G; Salazar Vizcaya, L; Metzner, K; Stöckle, M; Cavassini, M; Hoffmann, M; Lüthi, A; Suter, F; Bernasconi, E; Fehr, J; Furrer, H; Rauch, A (2018). Rapid decline of anti-hepatitis C virus (HCV) antibodies following early treatment of incident HCV infections in HIV-infected men who have sex with men. HIV medicine, 19(6), pp. 420-425. Blackwell Science 10.1111/hiv.12602
Kouyos, Roger D; Hasse, Barbara; Calmy, Alexandra; Cavassini, Matthias; Furrer, Hansjakob; Stöckle, Marcel; Vernazza, Pietro L; Bernasconi, Enos; Weber, Rainer; Günthard, Huldrych F; Aubert, V; Battegay, M; Bernasconi, E; Böni, J; Bucher, H C; Burton-Jeangros, C; Calmy, A; Cavassini, M; Dollenmaier, G; Egger, M; ... (2015). Increases in Condomless Sex in the Swiss HIV Cohort Study. Open Forum Infectious Diseases, 2(2), ofv077. Oxford University Press 10.1093/ofid/ofv077
Mühlethaler, K; Bögli-Stuber, K; Wasmer, S; von Garnier, C; Dumont, P; Rauch, A; Mühlemann, K; Garzoni, C (2012). Quantitative PCR to diagnose Pneumocystis pneumonia in immunocompromised non-HIV patients. European respiratory journal, 39(4), pp. 971-8. Sheffield, UK: European Respiratory Society 10.1183/09031936.00095811
Gasser, O; Brander, C; Wolbers, M; Brown, N V; Rauch, A; Günthard, H F; Battegay, M; Hess, C; Swiss HIV Cohort Study, (2012). Expansion of interferon-γ-secreting HIV-specific T cells during successful antiretroviral therapy. HIV medicine, 14(4), pp. 241-6. Oxford: Blackwell Science 10.1111/j.1468-1293.2012.01040.x
Stern, M; Czaja, K; Rauch, A; Rickenbach, M; Günthard, H F; Battegay, M; Fellay, J; Hirschel, B; Hess, C; Swiss HIV Cohort Study Group, (2012). HLA-Bw4 identifies a population of HIV-infected patients with an increased capacity to control viral replication after structured treatment interruption. HIV medicine, 13(10), pp. 589-95. Oxford: Blackwell Science 10.1111/j.1468-1293.2012.01019.x
Sambatakou, H; Dabis, F; Geffard, S; Smit, C; de Wolf, F; van der Meer, J; Peters, L; Puoti, M; Monforte, AD; Tural, C; Zinkernagel, A; Ledergerber, B; Rauch, A; de Witt, S; Suarez-Lozano, N (2012). Effect of hepatitis C treatment on CD4+ T-cell counts and the risk of death in HIV-HCV-coinfected patients: the COHERE collaboration. Antiviral therapy, 17(8), pp. 1541-50. London: International Medical Press
Rauch, A; European AIDS Treatment Network (NEAT) Acute Hepatitis C Infecti, (2011). Acute hepatitis C in HIV-infected individuals: recommendations from the European AIDS Treatment Network (NEAT) consensus conference. AIDS, 25(4), pp. 399-409. Hagerstown, Md.: Lippincott Williams & Wilkins 10.1097/QAD.0b013e328343443b
Combescure, Christophe; Vallier, N; Ledergerber, B; Cavassini, M; Furrer, H; Rauch, A; Battegay, M; Bernasconi, E; Vernazza, P; Hirschel, B (2009). How reliable is an undetectable viral load? HIV medicine, 10(8), pp. 470-6. Oxford: Blackwell Science 10.1111/j.1468-1293.2009.00714.x
Hurni, Ch; Rauch, A; Trost, N; Perrig, M; Bürgi, U; Schoenenberger, A W (2008). [Pulmonary nodules in a patient on long-term steroid treatment]. Praxis - schweizerische Rundschau für Medizin, 97(15), pp. 849-52. Bern: Huber
Clopath, C; Jolivet, R; Rauch, A; Luescher, H-R; Gerstner, W (2007). Predicting neuronal activity with simple models of the threshold type: Adaptive exponential integrate-and-fire model with two compartments. Neurocomputing, 70(10-12), pp. 1668-1673. Amsterdam: Elsevier 10.1016/j.neucom.2006.10.047
Rauch, A; Laird, R; McKinnon, E; Telenti, A; Furrer, H; Weber, R; Smillie, D; Gaudieri, S; the, Swiss HIV Cohort Study (2007). Influence of inhibitory killer immunoglobulin-like receptors and their HLA-C ligands on resolving hepatitis C virus infection. Tissue antigens, 69 Suppl 1, pp. 237-240. Oxford: Wiley-Blackwell 10.1111/j.1399-0039.2006.773_4.x
Rauch, A; Droz, S; Zimmerli, Stefan; Leib, Stephen L. (2006). Dysphagia in elderly women: consider tetanus. Infection, 34(1), pp. 35-38. Heidelberg: Urban & Vogel 10.1007/s15010-006-4151-7
Rauch, A; Nolan, D; Martin, A; McKinnon, E; Almeida, C; Mallal, Simon (2006). Prospective genetic screening decreases the incidence of abacavir hypersensitivity reactions in the Western Australian HIV cohort study. Clinical infectious diseases, 43(1), pp. 99-102. Cary, N.C.: The University of Chicago Press 10.1086/504874
Rauch, A; Rickenbach, M; Weber, R; Hirschel, B; Tarr, PE; Bucher, HC; Vernazza, P; Bernasconi, E; Zinkernagel, AS; Evison, J; Furrer, H; Swiss, HIV Cohort Study (2005). Unsafe sex and increased incidence of hepatitis C virus infection among HIV-infected men who have sex with men: the Swiss HIV Cohort Study. Clinical infectious diseases, 41(3), pp. 395-402. Cary, N.C.: The University of Chicago Press 10.1086/431486
Rauch, A; Egger, M; Reichen, J; Furrer, H; Swiss, HIV Cohort Study (2005). Chronic hepatitis C in HIV-infected patients: low eligibility and applicability of therapy with pegylated interferon-alpha plus ribavirin. Journal of acquired immune deficiency syndromes JAIDS, 38(2), pp. 238-40. Philadelphia, Pa.: Lippincott Williams & Wilkins 10.1097/01.qai.0000148535.97081.72
